AQP4 and myeloid sarcoma: Compared with patients diagnosed with MS or MOGAD, patients with AQP4-IgG NMOSD present with more severe attacks, lower recovery from attacks, and higher EDSS.22The disease is also responsible for a high impact on quality of life, chronic pain, and economic burden.48